This study examines the rate of decline of estimated glomerular filtration rate (eGFR) over a 10-year period and the associated risk factors in type 2 diabetes mellitus (T2DM) patients. Medical records of T2DM patients were randomly selected. The rate of fall in eGFR (simplified modification of diet in renal disease formula) was used as a measure of decline. Univariate and multivariate analysis were performed to determine the factors associated with decline of kidney function. A total of 504 patients were selected. Mean age was 57.8 ± 9 years; 65.3% were females. The mean decline rate of eGFR was 0.89 ± 2.16 mL/min/1.73 m2/y. Baseline proteinuria, glycosylated hemoglobin level, duration of T2DM, and Malay race were associated with faster decline in eGFR. The expected greater deterioration in kidney function in this cohort was not seen. Treatment of proteinuria and glycemia should be optimized early to retard the decline in kidney function in patients with T2DM.
Ministry of Health Malaysia. The Third National Health and Morbidity Survey (NHMS III) Diabetes Group. Kuala Lumpur, Malaysia: Ministry of Health Malaysia; 2006.
3.
RemuzziGSchieppatiARuggenentiP. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145-1151.
4.
ChiaYCChingSM. Hypertension and the development of new onset chronic kidney disease over a 10 year period: a retrospective cohort study in a primary care setting in Malaysia. BMC Nephrology. 2012;13:173.
5.
ChiaYCChingSM. Concordance of serum creatinine to estimated glomerular filtration rate in determining early chronic kidney disease in Malaysia. Life Sci J. 2012;9:453-457.
6.
National Kidney Foundation. K/DOQI clinical practice guideline for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.
7.
American Diabetes Association: Nephropathy in diabetes. Clinical practice recommendations. Diabetes Care. 2004;27:79-83.
8.
BakrisG. The importance of blood pressure control in the patients with diabetes. Am J Med. 2004;116(suppl 5A):30S-38S.
9.
AdlerAIStrattonIMNeilHA. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419.
10.
LeeheyDJKramerHJDaoudTM. Progression of kidney disease in type 2 diabetes—beyond blood pressure control: an observational study. BMC Nephrol. 2005;6:8.
11.
MurussiMGrossJLSilveiroSP. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric type 2 diabetic patients and normal individuals: a 10-year follow-up. J Diabetes Complications. 2006;20:210-215.
12.
YokoyamaHKannoSTakahashiS. Risks for glomerular filtration rate decline in association with progression of albuminuria in type 2 diabetes. Nephrol Dial Transplant. 2011;26:2924-2930.
13.
RiusFPizaroESalinasILucasASanmartiARomeroR. Age as a determinant of glomerular filtration rate in non-insulin-dependent diabetes mellitus. Nephrol Dial Transplant. 1995;10:1644-1647.
14.
EriksenBOIngebretsonOC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int Suppl. 2006;69:375-382.
15.
Chandie ShawPKBaboeFvan EsLA. South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care. 2006;29:1383-1385.
16.
CosmoSDLamacchiaORauseoA. Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes. Diabetes Care. 2006;29:2467-2470.
17.
CasesACollE. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int. 2005;68:87-93.
18.
RossingKChristensenPKHovindPTarnowLRossingPParvingHH. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004;66:1596-1605.
19.
BabazonoTHanaiKSuzukiK. Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia. 2006;49:1387-1393.
20.
ThomasethKPaciniGMorelliPTonoloGNosadiniR. Importance of glycemic control on the course of glomerular filtration rate in type 2 diabetes with hypertension and microalbuminuria under tight blood pressure control. Nutr Metab Cardiovasc Dis. 2008;18:632-638.
21.
AltemtamNRussellJEl NahasM. A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant. 2012;27:1847-1854.
22.
AlwakeelJSIsnaniACAlsuwaidaA. Factors affecting the progression of diabetic nephropathy and its complications: a single-center experience in Saudi Arabia. Ann Saudi Med. 2011;31:236-242.
23.
BrennerBMCooperMEZeeuwDD. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861-869.
24.
RemuzziGBertaniT. Is glomeruloscierosis a consequence of altered glomerular permeability to macromolecules?Kidney Int. 1990;38:384-394.
25.
LiuWJHooiLS. Patients with end stage renal disease: a registry at Sultanah Aminah Hospital, Johor Bahru, Malaysia. Med J Malaysia. 2007;62:197-200.
26.
SabanayagamCLimSCWongTYLeeJShankarATaiES. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant. 2010;25:2564-2570.
27.
ThomasethKPaciniGMorelliPTonoloGNosadiniR. Importance of glycemic control on the course of glomerular filtration rate in type 2 diabetes with hypertension and microalbuminuria under tight blood pressure control. Nutr Metab Cardiovasc Dis. 2008;18:632-638.
28.
ShahinfarDTZhangZXKeaneWFBrennerBM; RENAAL Investigators. Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: new lessons from the RENAAL Study. Kidney Int Suppl. 2005;(93):S48-S51.
